194 related articles for article (PubMed ID: 17016580)
1. Preferentially enhanced gene expression from a synthetic human telomerase reverse transcriptase promoter in human cancer cells.
Kim SJ; Lee HS; Shin JH; Kim CG; Jeong S; Park K; Choe H; Lee H
Oncol Rep; 2006 Nov; 16(5):975-9. PubMed ID: 17016580
[TBL] [Abstract][Full Text] [Related]
2. Development of artificial chimerical gene regulatory elements specific for cancer gene therapy.
Shin JH; Yi JK; Lee YJ; Kim AL; Park MA; Kim SH; Lee H; Kim CG
Oncol Rep; 2003; 10(6):2063-9. PubMed ID: 14534744
[TBL] [Abstract][Full Text] [Related]
3. Telomerase reverse transcriptase promoter regulation during myogenic differentiation of human RD rhabdomyosarcoma cells.
Ma H; Urquidi V; Wong J; Kleeman J; Goodison S
Mol Cancer Res; 2003 Aug; 1(10):739-46. PubMed ID: 12939399
[TBL] [Abstract][Full Text] [Related]
4. Upstream stimulatory factor (USF) as a transcriptional suppressor of human telomerase reverse transcriptase (hTERT) in oral cancer cells.
Chang JT; Yang HT; Wang TC; Cheng AJ
Mol Carcinog; 2005 Nov; 44(3):183-92. PubMed ID: 16010690
[TBL] [Abstract][Full Text] [Related]
5. Detection of cell cycle- and differentiation stage-dependent human telomerase reverse transcriptase expression in single living cancer cells.
Edqvist A; Rebetz J; Järås M; Rydelius A; Skagerberg G; Salford LG; Widegren B; Fan X
Mol Ther; 2006 Jul; 14(1):139-48. PubMed ID: 16584924
[TBL] [Abstract][Full Text] [Related]
6. Opposing regulatory roles of E2F in human telomerase reverse transcriptase (hTERT) gene expression in human tumor and normal somatic cells.
Won J; Yim J; Kim TK
FASEB J; 2002 Dec; 16(14):1943-5. PubMed ID: 12368233
[TBL] [Abstract][Full Text] [Related]
7. [The efficacy of autocatalytic casapse-3 driven by human telomerase reverse transcriptase promoter on human ovarian carcinoma].
Song Y; Shen K; Yu JR
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(41):2919-24. PubMed ID: 18261307
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional targeting in ovarian cancer cells using the human epididymis protein 4 promoter.
Berry NB; Cho YM; Harrington MA; Williams SD; Foley J; Nephew KP
Gynecol Oncol; 2004 Mar; 92(3):896-904. PubMed ID: 14984958
[TBL] [Abstract][Full Text] [Related]
9. Tumor-specific expression detected with the use of an expression vector driven by human telomerase reverse transcriptase gene promoter.
Yin J; Fu P; Wang X; Jin G; Xiu R
J Lab Clin Med; 2004 Dec; 144(6):302-6. PubMed ID: 15614252
[TBL] [Abstract][Full Text] [Related]
10. hTERT promoter induces tumor-specific Bax gene expression and cell killing in syngenic mouse tumor model and prevents systemic toxicity.
Gu J; Andreeff M; Roth JA; Fang B
Gene Ther; 2002 Jan; 9(1):30-7. PubMed ID: 11850720
[TBL] [Abstract][Full Text] [Related]
11. [Expression of osm gene driven by hTERT gene promoter inhibits cancer cells proliferation in vitro].
Yang YJ; Zheng XF; Zhu J; Lu X; Luo Y; Sun ZX
Ai Zheng; 2003 Jun; 22(6):575-8. PubMed ID: 12948403
[TBL] [Abstract][Full Text] [Related]
12. Cloning and characterization of the promoter region of human telomerase reverse transcriptase gene.
Horikawa I; Cable PL; Afshari C; Barrett JC
Cancer Res; 1999 Feb; 59(4):826-30. PubMed ID: 10029071
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of hTERT expression plays an important role in 15-deoxy-Delta12,14-prostaglandin J2-induced apoptosis in cancer cells.
Moriai M; Tsuji N; Kobayashi D; Kuribayashi K; Watanabe N
Int J Oncol; 2009 May; 34(5):1363-72. PubMed ID: 19360348
[TBL] [Abstract][Full Text] [Related]
14. [Construction of autocatalytic caspase-3 driven by amplified human telomerase reverse transcriptase promoter and its enhanced efficacy of inducing apoptosis in human ovarian carcinoma].
Song Y; Shen K; He CX
Zhonghua Fu Chan Ke Za Zhi; 2007 Sep; 42(9):617-22. PubMed ID: 17983518
[TBL] [Abstract][Full Text] [Related]
15. Differential transcriptional regulation of human telomerase in a cellular model representing important genetic alterations in esophageal squamous carcinogenesis.
Quante M; Heeg S; von Werder A; Goessel G; Fulda C; Doebele M; Nakagawa H; Beijersbergen R; Blum HE; Opitz OG
Carcinogenesis; 2005 Nov; 26(11):1879-89. PubMed ID: 15958520
[TBL] [Abstract][Full Text] [Related]
16. Telomerase-specific suicide gene therapy vectors expressing bacterial nitroreductase sensitize human cancer cells to the pro-drug CB1954.
Plumb JA; Bilsland A; Kakani R; Zhao J; Glasspool RM; Knox RJ; Evans TR; Keith WN
Oncogene; 2001 Nov; 20(53):7797-803. PubMed ID: 11753658
[TBL] [Abstract][Full Text] [Related]
17. IFN-gamma/IRF-1-induced p27kip1 down-regulates telomerase activity and human telomerase reverse transcriptase expression in human cervical cancer.
Lee SH; Kim JW; Oh SH; Kim YJ; Rho SB; Park K; Park KL; Lee JH
FEBS Lett; 2005 Feb; 579(5):1027-33. PubMed ID: 15710386
[TBL] [Abstract][Full Text] [Related]
18. Introduction of p16INK4a inhibits telomerase activity through transcriptional suppression of human telomerase reverse transcriptase expression in human gliomas.
Saito M; Nakagawa K; Hamada K; Hirose S; Harada H; Kohno S; Nagato S; Ohnishi T
Int J Oncol; 2004 May; 24(5):1213-20. PubMed ID: 15067344
[TBL] [Abstract][Full Text] [Related]
19. Expression of a recombinant vector of a mutant human telomerase reverse transcriptase gene in human bladder cancer cell line T24, and its clinical significance.
Fu WJ; Hong BF; Huang JJ; Xu B; Gao JP; Wang XX; Huang CF
BJU Int; 2005 Oct; 96(6):890-4. PubMed ID: 16153224
[TBL] [Abstract][Full Text] [Related]
20. Oncolytic adenovirus that overproduces ADP and replicates selectively in tumors due to hTERT promoter-regulated E4 gene expression.
Kuppuswamy M; Spencer JF; Doronin K; Tollefson AE; Wold WS; Toth K
Gene Ther; 2005 Nov; 12(22):1608-17. PubMed ID: 16034456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
